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Abstract
Objective—Few decision aids emphasize active surveillance for localized prostate cancer. 
Concept mapping was used to produce a conceptual framework incorporating active surveillance 
and treatment.
Methods—54 statements about what men need to make a decision for localized prostate cancer 
were derived from focus groups with African American, Latino, and white men previously 
screened for prostate cancer and partners (n=80). In the second phase, 89 participants sorted and 
rated the importance of statements.
Results—An 8 cluster map was produced for the overall sample. Clusters were labelled Doctor-
patient exchange, Big picture comparisons, Weighing the options, Seeking and using information, 
Spirituality and inner strength, Related to active treatment, Side effects, and Family concerns. A 
major division was between medical and home-based clusters. Ethnic groups and genders had 
similar sorting, but some variation in importance. Latinos rated Big picture comparisons as less 
important. African Americans saw Spirituality and inner strength most important, followed by 
Latinos, then whites. Ethnic- and gender-specific concept maps were not analyzed because of high 
similarity in their sorting patterns.
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Conclusions—We identified a conceptual framework for management of early stage prostate 
cancer that included coverage of active surveillance. Eliciting the conceptual framework is an 
important step in constructing decision aids which will address gaps related to active surveillance.
More than 80% of prostate cancer diagnoses in the U.S. are for localized disease, confined 
to the prostate and about 80%–90% of men diagnosed with low-risk prostate cancer receive 
some form of treatment (1–2). There is currently uncertainty about the management of 
localized prostate cancer. Surgery and radiation, the most common treatments, have largely 
equivalent survival rates and each result in significant risk of urinary, bowel and sexual 
problems (3–4). Comparisons of active surveillance (AS) and surgery for low-risk disease 
have shown small advantages associated with surgery or no differences in survival (5–6). 
There is concern that the growth in early detection and immediate treatment have led to 
treatment of cancers not likely to be clinically significant.
The 2011 U.S. National Institutes of Health (NIH) Consensus and State-of-the-Science 
Conference concluded that AS should be offered to patients with low-risk prostate cancer 
(3). Active surveillance is defined as a management strategy that delays treatment until it is 
warranted based on indicators of disease progression. It is differentiated from watchful 
waiting, in which treatment is introduced to relieve symptomatic disease progression. Low-
risk prostate cancer is usually determined by such characteristics as a) tumor stage of being 
not detectable clinically or with imaging or a small tumor able to be felt but confined to the 
prostate, b) PSA value of less than 10 μg/L, and c) histologic grade or Gleason score of less 
than or equal to 6.
A number of decision aids have been developed for early stage localized prostate cancer (7). 
However, these decision aids frequently give little attention to AS and may not clearly 
distinguish it from watchful waiting (8).
Decision aids tend to be developed on more highly educated men (9). Moving beyond 
affluent patient populations will require learning whether less advantaged groups, potentially 
of different ethnicities, have different views of the treatment options. It will be important for 
decision aids for prostate cancer treatment decisions to address the information needs and 
incorporate the conceptual frameworks of these men.
Research on treatment decisions is useful in understanding how patients think about their 
options. Survival and getting rid of cancer are commonly cited factors in the treatment 
decision (10). Persons choosing some form of radiation therapy often say they want to avoid 
surgery (11). Patients express concern about the treatment side effects of incontinence, 
impotence and bowel problems, but do not report them as pivotal to the decision (10, 12).
Few studies have focused on patients’ reasons for selecting active surveillance. Only a 
minority of low-risk prostate cancer patients enroll in an AS protocol and approximately 
10% to 50% of those men elect secondary treatment, despite an absence of clinical disease 
progression (13–14). Men selecting AS emphasized the importance of avoiding side effects. 
They also noted the importance of physician support for AS (15). Qualitative research done 
as part of the PROTECT trial comparing active surveillance, surgery, and radiation therapy 
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has shown that information about the options can be presented such that men accept AS as 
an option in relation to the major treatments (16).
Studies in the USA examining variation in treatments by race or ethnicity or socio-economic 
position have found that African Americans and Latinos were less likely to be treated with 
surgery or radiation therapy, and were monitored less frequently than whites during the five-
year period (17–18). These studies show ethnic variations in treatment selection and 
experience and the importance of high quality observant management strategies. However, it 
is important to note that these studies combined watchful waiting and unknown treatment 
categories which reinforces the importance of clear definitions of active surveillance and 
watchful waiting.
The views of the spouse may also influence decisions. Men say that they want their partners 
involved, and physicians commonly involve men’s partners in discussions of management 
options (10). However, husbands and wives may value outcomes of treatment differently, 
for example, in one study wives placed higher value on survival and a lower one on avoiding 
side effects than husbands (19). Single or separated men had higher rates of watchful 
waiting, while married men were more likely to be treated by radical prostatectomy (20–21).
The primary aim of this study was to learn more about the conceptual framework and 
information needs of men and partners in relation to considering active surveillance if they 
were facing a decision for early stage, localized prostate cancer. A secondary aim was to 
examine variation in the conceptual framework by ethnicity and gender. The results will be 
used to inform the development of patient education and decision support tools to support 
treatment decisions for localized prostate cancer.
Methods
Overview
Concept mapping is a participatory mixed qualitative-quantitative method that results in a 
graphical view of a group’s ideas about a topic and the relations among them (22–24). The 
general sequence of activities is 1) to generate a set of statements about a particular topic, 2) 
sorting and rating of the statements, 3) statistical analysis, and 4) interpretation of the 
concept map. The term concept map has also been used to show important attributes related 
to a concept, sometimes based on content analysis of the scientific literature (25).
Sometimes the sequence of steps involves a single group of participants. We modified that 
procedure such that overlapping groups of people took part in the different steps. This was 
done to reduce the burden of participation (26).
Participants
We chose convenience samples of African American, Latino, and White, non-Hispanic men 
in Houston and El Paso, Texas, USA. Eligible men were 50–70 years of age or 40–70 years 
if African American, had a PSA test within the previous two years, and had never been 
diagnosed with or tested positive for prostate cancer. The recruited participants represent 
men interested in prostate cancer screening but who have not faced the treatment decision or 
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its side effects. In recruitment, men were asked if they wished to bring a partner, that is, a 
person he would involve in health decisions. Partner sessions were conducted separately. 
Sessions took place between May 2010 and February 2011.
In Houston, African American men were recruited by an outreach programme of a 
comprehensive cancer center. Non-Hispanic white men were recruited using flyers and local 
newspaper advertisements. In El Paso, a community cancer education organization recruited 
Latino and non-Hispanic white men. Participants received $75 for their time and parking 
($50 in El Paso).
Statement generation
Statements about prostate cancer treatment/management were drawn from focus groups and 
from research reports.
Focus groups were homogeneous with respect to gender, ethnicity, and language (English, 
Spanish). Participants gave written consent and completed a background questionnaire. The 
focus groups began with an overview of active treatments for early-stage prostate cancer 
(i.e., radical prostatectomy, beam radiation, and brachytherapy) and their potential side 
effects so that the discussion had a base of information. This segment featured a 3½ minute 
video on prostate cancer and treatment options (27) and a 2½ minute video extract about 
treatments and AS (28).
The discussion was about how they would make treatment decisions if they (or their 
partners) were diagnosed with early-stage, localized prostate cancer. It covered what 
information is needed, how they would think about or evaluate information, and who they 
would involve in the decision. The discussion moderator asked the participants specific 
questions about the treatment options described in the videos.
Sessions were audio-taped, transcribed, and translated, if in Spanish. The translation was 
reviewed by bilingual coders to ensure that there was good correspondence with the original 
transcripts.
Coding statements
Pairs of reviewers independently extracted excerpts from the transcripts that related to the 
focal prompt: “When deciding what to do for early-stage, localized prostate cancer, a man 
should…”. The result was short statements summarizing ideas from the focus group 
discussion. Disagreements about coded statements were resolved in team meetings.
We added a few statements from studies of decision making for early-stage, localized 
prostate cancer. Articles were restricted to studies of men in the midst of a treatment 
decision or a hypothetical decision. Studies of past decisions were excluded. The decision 
alternatives included active surveillance or watchful waiting. Of 12 articles that met our 
eligibility criteria, ten were found by two independent reviewers to have relevant content. 
Following the editing, six statements were added.
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Statements were edited to eliminate redundancy, correct double-barreled statements, and 
simplified such that the reading levels did not exceed 6th grade Flesch-Kincaid. The final list 
had 54 statements. Statements were translated into Spanish and reviewed by native Spanish 
speakers. (The Spanish translations can be obtained from the corresponding author.) 
Statements were randomly ordered and printed on card stock. Cards for Spanish-speaking 
participants had the English statement on one side and Spanish on the other.
Sorting and rating
Participants independently sorted cards within small groups homogeneous in ethnicity, 
gender and language. The same video clips and handouts from the focus groups were shown 
to inform participants about treatment alternatives and active surveillance.
Each participant was asked to sort the cards according to their similarity, so that those seen 
as most similar in meaning were in the same pile, making as many piles as he/she wanted. 
The focus prompt for sorting was “When deciding what to do for early-stage, localized 
prostate cancer, a man should…”. Participants were encouraged to have at least three piles, 
no “miscellaneous” pile, and no single statement piles.
After sorting, participants rated the statements for their importance (compared to the rest) in 
making a decision. Response alternatives were 1=relatively unimportant, 2=somewhat 
important, 3=moderately important, 4=very important, and 5=extremely important.
Analysis and identification of clusters based on sorting
We used The Concept System software (29) for analysis. We produced a binary symmetric 
54 by 54 matrix for each sorter where cell entries of “1” indicate that two statements were 
placed together in a pile and “0” otherwise. The individual binary matrices were summed 
across sorters to produce an aggregate matrix where cell entries were the number of 
participants placing each pair of statements in the same pile. A map in two dimensions, 
convenient for displaying the relationships among the statements, was produced with 
multidimensional scaling (MDS) (23, 30). The distance between points (statements) 
represents the estimates from MDS of how similar they are judged to be. The position of 
each point on the map (e.g., top, bottom, right, left) is not important — only the distance.
The MDS spatial coordinates were analyzed using hierarchical cluster analysis with Ward’s 
algorithm (31) to produce non-overlapping clusters of more similar statements. Cluster 
boundaries enclose the statements grouped in each cluster. The size and shape of a cluster 
generally corresponds with whether it is a broader or narrower conceptual area (23).
We examined a range of cluster solutions (5 to 10) to determine the appropriateness of 
merging or splitting of statement groups, and selected the 8 cluster solution. The central 
decision described here is the number of clusters. The content of clusters or the cluster tree 
structure is statistically determined, but the “best” number of clusters depends on the level of 
specificity desired and context, factors judged substantively (23).
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Interpretation of concept map
Researchers and a subset of participants interpreted the concept map. The research team 
selected the number of clusters and proposed preliminary labels shaped by the statements 
included in the clusters, their importance ratings, and the bridging values of clusters. 
Clusters of statements with low bridging values are more cohesive.
Six groups of community participants discussed the maps in gender-specific discussion 
sessions. They looked at the statements in each cluster and discussed what the cluster means 
to them. At the conclusion, men and their partners reassembled to discuss their joint 
reactions. The paired interpretations of participants and research group ensured that the 
researchers’ interpretations did not diverge too far from the participants.
The study was approved by the Committee for the Protection of Human Subjects, The 
University of Texas Health Sciences Center and the Institutional Review Board of The 
University of Texas MD Anderson Cancer Center.
Results
A total of 80 individuals (45 men and 35 women) participated in statement generation 
sessions, 89 participants (52 men and 36 women) took part in sorting and rating, and 33 
individuals (19 men and 14 women) participated in the interpretation step. The totals include 
43 persons, 21 in Houston and 22 in El Paso, from the statement generating focus groups 
who also participated in the sorting and rating phase. All 18 persons in the El Paso 
interpretation groups were prior participants, as were 9 of 15 in Houston.
To simplify the presentation, Table 1 describes participants in the sorting/rating phase. 
There were equal numbers of participants from Houston and El Paso, and an approximately 
even ethnic distribution. There were more men than women, since some men did not invite a 
partner and some brought a male friend or family member. There was a fair amount of 
variation in education level. Six sorting and rating participants (3 African American, 2 
Latino, and 1 non-Hispanic white) were excluded from the analysis because their sorts had 
three or fewer piles.
One analytic decision was whether to present separate analyses based on the sorts of a single 
race/ethnicity or gender. We selected the combined map (all ethnic groups, both genders) 
based on the high correlation of the sorts made by groups. The correlation of statement 
similarities between ethnic groups or gender ranged from 0.93 to 0.95 when corrected with 
the Spearman-Brown prophecy formula [31].
Figure 1 shows the 8-cluster map for the combined sample. The text for each numbered 
statement can be seen in Table 2. The locations of individual statements (points) are 
indicated with numbers. The clusters are labelled with brief descriptions. The overall fit or 
stress value was 0.21, an acceptable value (lower stress values indicate better fit) (30).
Taken together, the four clusters located toward the right side of the map refer to seeking 
medical information (Figure 1) and compare AS and active treatments, i.e., surgery and 
radiation therapy. This set of clusters had the highest importance ratings.
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The cluster Doctor-patient exchange has the highest average importance rating. Its 
statements include “finding a doctor he is comfortable with”, “asking for information”, and 
“obtaining a second opinion”. The statements also include “seeking clarification when he 
does not understand the doctor”. In the interpretation, participants emphasized the 
importance of communicating with the doctor. One comment was, “Here, it seems like you 
are doing more communicating -- kind of reaching out a little bit. Ask for the information 
that you need…and this is communicating with the doctor” (African American men).
Seeking and using information is not so strictly focused on the doctor as the information 
source. It includes statements about how a man should make the decision, such as being 
willing to talk about what he wants, realizing that there is a choice to be made, and opening 
himself up to information from such sources as cancer survivors, other types of health 
personnel and the Internet. It characterizes the man as a person who actively participates in 
the treatment decision, reaching out for information. He is seen as deciding about the level 
of input he wants from the doctor. The cluster emphasizes participating in making treatment 
decisions and reaching out to the man’s network.
The cluster Big picture comparison has statements fundamentally comparing active 
treatments and AS. Statements include “knowing that active surveillance is an option”, 
“finding out what would be done in treatment and active surveillance”, and the survival rates 
under the two strategies. Pointing to the central theme of comparison, one participant 
summarized, “You may decide you want active surveillance. You may decide you want 
active treatment. That’s about as far apart as they get” (non-Hispanic white men).
The cluster Weighing the options has more specific statements about active treatments and 
AS than the Big picture comparison. Statements related to AS include “having a similar 
length of life to treated men”, “a man may worry about the spread of cancer if it is not 
treated”, the “need to return for frequent examinations with active surveillance”, and “a man 
selecting active surveillance can choose to be treated later”. Statements focused on active 
treatment include “men should weigh the overall risks and benefits of treatments”, “active 
treatment is associated with a similar length of life to active surveillance”, and “there is risk 
of recurrence following treatment”.
We have grouped together two clusters on the left side of the map as related to faith and 
family. They are the farthest from the medical clusters.
“Spirituality and inner strength” has statements about “looking to faith for guidance”, 
“thinking how family members would feel if the man chose active surveillance” or 
alternatively “if he chose active treatment and suffered side effects”. Participants at the 
interpretation sessions proposed the label “Hold on to your faith and stay positive” (non-
Hipanic white partners). They also suggested “Different ways of coping,” because they 
noted, “Some will use faith and some will use family and friends.”
The cluster, Family concerns, has statements related to balancing men’s views with those of 
his family. These include making sure family members get information and weighing or 
balancing what is valued by the man and his family. There is an interesting confluence of 
statements about taking the time needed to make the decision and both including and 
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resisting the influence of others. Participants labelled it “Consideration of self and loved 
ones in the decision-making process” (African American men). They described the cluster as 
being about getting input from friends and family in the decision.
The final two clusters bridge the medical and family/spirituality large groups of clusters. 
Related to active treatment is about general features of the treatment decision. One 
statement is about the slow growing nature of much prostate cancer such that older men may 
die with, rather than from, prostate cancer. Another statement is the nearly opposite view of 
thinking about how important it is to rid the body of cancer. Two statements in the cluster 
had high bridging values indicating that they were not sorted consistently. These were 
statements about access to treatment depending on where the man lives, his income or race/
ethnicity and about how the financial costs of treatment will be borne.
Side effects, a tightly focused cluster, has statements about the effects of treatment on male 
identity and sex life and the importance of thinking about how strongly the man wishes to 
avoid side effects. Participants labelled the cluster as having to do with the side effects of 
treatment or more generally about quality of life.
Variation in cluster importance
For most clusters there was no variation by ethnicity in the importance of clusters. There 
was ethnic variation in the average importance of three of eight clusters. Latino/as rated 
most clusters as less important than the other ethnic groups, though few differences were 
statistically significant. One exception was Big picture comparisons. Spirituality and inner 
strength also varied by ethnicity with African Americans having highest importance ratings, 
followed by Latinos, then by non-Hispanic whites. African Americans also rated the Related 
to treatment cluster as most important.
Men and women rated the importance of the clusters similarly for the most part. The two 
exceptions were that women rated Weighing the options and Seeking and using information 
as more important than men. Women seemed to value searching out information and 
actively evaluating options. One group of female participants described the importance of 
going on a “fact-finding mission,” to assist the man in his decision about prostate cancer 
management. It is interesting that the importance ratings for clusters Side effects of active 
treatment and Family considerations were similar for men and women.
Discussion and conclusion
The NIH Consensus Conference recommended that men with localized low-risk prostate 
cancer be offered the option of AS. Active surveillance has been neglected in decision aids 
or not distinguished from watchful waiting (8–9), though this gap is beginning to be 
addressed. Therefore, in this study, we used concept mapping to elicit perspectives of men 
and partners related to active treatment and active surveillance for low-risk prostate cancer.
According to the concept map, participants distinguish overall and detailed comparisons of 
AS and treatment. They also see a contrast between ideas related to how to gather 
information and how to engage with their physicians to find the needed information for 
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decision making. The topic of side effects of treatment was also seen in the conceptual 
framework.
The higher importance of more factually oriented clusters suggests that men and partners 
define factual information as being a key component of the treatment decision. Thus, a 
decision aid should include content about the nature of prostate cancer, what is involved and 
outcomes for the alternatives. This is consistent with the information function of a decision 
aid, in which options are clearly described and contrasted (32).
Decision aids should also have content about how to engage in the decision, for example, 
how to interact with the physician to get necessary information and suggestions for how to 
express his preferences for particular outcomes. This type of information is also represented 
in the clusters and is consistent with the deliberative function of patient decision aids (32).
The conceptual framework also shows the relation of family and spiritual values in the 
treatment decision. Partners anticipated having a role in the treatment decision, describing 
themselves as finding things out, taking notes or helping the man to remember, and 
encouraging him to be an active participant in the decision. Men and partners do not 
necessarily expect to have the same views. Nevertheless, the high correlation of the sorts 
suggests that men and their partners do not greatly vary in how statements are grouped 
although there may be some differences in the level of importance of statements.
Eliciting the conceptual framework is an important step in constructing decision aids that 
resonate with the decision makers (33). The concept map was built on a rich base of 
qualitative information from ethnically diverse men and partners. The participants engaged 
in the statement generating discussions, sorted and rated statements and interpreted the 
concept maps.
While our study had sufficient numbers of participants in the three race/ethnicity groups to 
conduct comparative analyses, we selected a combined map. There was high cross-gender 
and ethnic group similarity in the sorting and reasonably similar importance ratings of 
statements. While designers of decision aids may wish to target certain features of their 
product to different ethnic groups, these analyses suggest that major modifications in content 
are not important. Participation by ethnic minority men and partners in these formative steps 
does help ensure that any resulting decision aid has a better chance of resonating with their 
concerns.
One limitation of the study was that it was conducted with men with no history of prostate 
cancer. We tried to compensate for their relative lack of information by providing an 
overview of treatments and AS. Participants thus had more understanding of the outcomes 
of treatments and AS, but they did not have strong views associated with the treatment 
experience, e.g., preference for their own treatment or decisional regret (34). However, it is 
possible that men facing a diagnosis of prostate cancer may have different views of the 
treatment options. To address these concerns, we are investigating conceptualizations of 
active surveillance among men who chose AS or immediate treatment for localized prostate 
cancer.
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We used concept mapping to identify a conceptual framework incorporating AS and other 
treatments for early stage prostate cancer. Eliciting the conceptual framework is an 
important step in constructing decision aids. This application of concept mapping has been 
useful in showing knowledge and processes to support decisions for localized prostate 
cancer. It addresses gaps in covering AS.
The 2011 NIH Consensus Conference recommended that men with localized low-risk 
prostate cancer be offered AS (3). We used concept mapping to examine the conceptual 
frameworks of an ethnically diverse group of men and partners related to the management of 
localized prostate cancer. Major modifications in content for members of different ethnic 
groups do not appear to be required based on this analysis. The findings from the study will 
help design interventions to promote informed management decisions for patients with 
localized prostate cancer where active surveillance may be an option.
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Table 1




El Paso 44 49
Male 57 64
Age
Less than 50 years 14 16
50–59 27 31
60 or more years 47 53
Ethnicity
African American 31 35
Hispanic 30 34
White Non-Hispanic 28 31
Education
Less than high school 21 24
High school graduate 26 30
More than high school 41 46
Total 89
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Table 2
Clusters, ordered by mean importance, with text of statements, statement numbers and mean importance 
ratings of statements
Cluster label Statement (statement number) Mean SD
Doctor-patient exchange Find a doctor he is comfortable with (54) 4.50 0.86
Find out about all of the possible treatments (50) 4.32 0.90
Know what care would be needed after treatment (53) 4.28 0.93
Tell his doctor if there’s something he doesn’t understand (47) 4.23 0.94
Ask for the information he wants to know (48) 4.16 0.95
Ask for the most up-to-date information (45) 4.10 1.20
Ask for a second opinion from another doctor (44) 4.06 1.06
Ask if it is helpful to use natural or alternative medicine (for example, herbs or acupuncture) 
to treat his cancer (2)
3.30 1.40
Big picture comparisons Find out the survival rates of active treatment and active surveillance. (This means how 
likely a man is to still be alive five years from diagnosis) (18).
4.07 1.16
Ask about the risk that the cancer will spread during treatment (9) 4.02 1.14
Find out exactly what would be done during active treatment or active surveillance (17) 3.99 1.02
Find out if anything can be done about treatment side effects if they happen (10) 3.90 1.09
Know that active surveillance is also an option (38) 3.78 0.95
Weighing options Compare the risks and benefits of active treatment (5) 4.18 0.89
Consider what effects the active treatment might have on his bowel or urinary function (15) 4.05 1.08
Consider the risk that the cancer may come back after active treatment (8) 4.06 1.02
Compare the risks and benefits of active surveillance (6) 4.06 0.99
Know that he will probably live just as long, whether he chooses active treatment or active 
surveillance (25)
4.01 1.17
Understand that if he chooses active surveillance, he may feel worried about the cancer 
spreading (7)
3.98 1.18
Think about how willing he is to return for frequent exams if he chooses active surveillance 
(30)
3.76 1.02
Know that if he chooses active surveillance, he can still change his mind later (20) 3.72 1.24
Ask whether he’s likely to have a bad health care experience like one he may have had in the 
past (for example, slow recovery from surgery) (4)
3.59 1.10
Consider how often and for how long he would need to go to the clinic or hospital (16). 3.49 1.13
Seeking and using information Decide how much input he wants from his doctor in the final decision (29) 4.17 0.89
Make sure to get his doctor’s opinion (42) 4.05 0.91
Realize that he has a choice (39) 4.05 1.00
Do things to help him remember the information that doctors give him (for example, taking 
notes, having someone else go with him) (51)
4.02 1.01
Be willing to talk about which treatment he’d rather have (28) 3.92 1.22
Get information from other places such as the Internet (49) 3.85 1.04
Find out about other people’s experiences with early stage prostate cancer, both with active 
surveillance and active treatment (33)
3.70 1.15
Talk to another healthcare worker, such as a nurse or promoter/a (43) 3.28 1.20
Spirituality and inner strength Think about how his positive frame of mind will help him cope with whatever happens (36) 4.17 1.03
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Cluster label Statement (statement number) Mean SD
Look to his faith for strength and guidance when making the decision (35) 4.10 1.19
Consider how much help he will need from family and friends during active treatment and 
recovery (34)
3.83 1.05
Consider how family members would feel if he had side effects from active treatment (32) 3.42 1.29
Consider how family members would feel if he chose active surveillance (31) 3.37 1.19
Related to active treatment Be aware that the older he is, the slower the cancer may grow or spread (1) 3.94 1.03
Consider how strongly he feels about doing something right away to get rid of the cancer 
(22)
3.92 1.29
Consider how long it will take to recover (19) 3.91 0.99
Consider that he may be given fewer treatment options, depending on where he lives, his 
income, or his race/ethnicity (24)
3.82 1.22
Evaluate how much of the cost of treatment or of active surveillance will have to be paid out 
of his pocket (e.g., travel costs or co-payments) (21)
3.70 1.36
Consider the effect that active treatment might have on his ability to have children (12) 2.98 1.66
Side effects Consider that active treatment may be harder on him than active surveillance if he is in poor 
health, has other health conditions, or is older (3)
4.17 1.01
Consider the effects of active treatment on his usual activities (11) 3.86 1.02
Consider how strongly he feels about avoiding side effects of active treatments (23) 3.80 1.10
Consider the effect that active treatment might have on his sex life (13) 3.48 1.41
Consider the effect that active treatment might have on his sense of manhood (14) 3.23 1.48
Family concerns Consider what is important both to him and to his loved ones (37) 4.23 1.02
Say what’s important to him in choosing what to do (27) 4.00 1.06
Make sure loved ones get the information they want (52) 3.94 1.11
Take as much time as he needs to make the best decision for him (40) 3.88 1.08
Include family members in making the decision (41) 3.71 1.17
resist pressure from others about what to do (26) 3.52 1.41
Ask friends for advice (46) 2.66 1.24
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